ILCA School of Liver Cancer, Chicago, USA

HomeEducationILCA School of Liver Cancer, Chicago, USA

ILCA School of Liver Cancer, Chicago, USA

In a collaborative multidisciplinary effort between Northwestern University and Rush University, The University of Chicago, and Loyola University, we are happy to announce that Chicago, Illinois was chosen for this edition of the ILCA School of Liver Cancer 2022.

The ILCA School is a unique learning platform for practitioners and investigators to receive education in an intense, interactive, and multidisciplinary format. Topics will include hepatocellular carcinoma and cholangiocarcinoma.

Date: Thursday, May 26  8:00 am – 5:00 pm, Friday, May 27 8:0 am to 11:45 am
Location: Hyatt Centric, 633 N St Clair St
Target audience:  MD/DO, APP, RNs, trainees, students
Admission Cost: Free registration, limited to 90, first-come first-served, seating will respect social distancing policy

Registrations are open!

We only have 3 complimentary registrations left. Hurry up and get yours now!

Programme

Day 1: Thursday May 26, 2022
Chicago Time (GMT -5)
07:15 – 08:00 Breakfast and Sign in
08:00 – 08:15 Welcome Address
Riad Salem MD, MBA (Chief, Interventional Radiology)
IMAGING AND MANAGEMENT OF HCC
(Chair: Robert Lewandowski MD)
08:15 – 08:30 Screening for HCC
Amit Singal (Professor, Hepatology, Univ of Texas)
08:30 – 08:45 Imaging diagnosis of HCC and LI-RADS
Amir Borhani (Professor, Radiology, Northwestern)
08:45 – 09:00 Staging of HCC: What’s the best system?
Laura Kulik (Professor, Hepatology, Northwestern)
THE GLOBAL IMPACT OF HCC
09:00- 09:30 Ghassan-Abou Alfa, MD
(Professor of Medical Oncology, Weill-Cornell University, Memorial Sloan Kettering Cancer Center, New York, New York)
09:30- 09:45 Q&A
09:45 – 10:00 Coffee Break & Networking
SURGICAL MANAGEMENT OF HCC
(Chair: Juan Caicedo MD)
10:00- 10:20 Transplantation: State of the Art
Karim Halazun, MD (Chief of Transplantation, NYU Langone, New York)
10:20 – 10:40 Surgical Resection: Novel approaches
Juan Caicedo, MD (Professor of Transplant Surgery, Northwestern)
MEDICAL MANAGEMENT OF HCC
(Chair: Aparna Kalyan MD)
10:40 – 11:00 NASH related HCC treatments- the known and unknowns
Anjana Pillai, MD (Associate Professor, Hepatology, University of Chicago)
11:00 – 11:20 FIRST AND SECOND LINE THERAPIES FOR HCC: Here’s the rundown
Ghassan Abou-Alfa, MD (Professor of Medical Oncology, Weill-Cornell University, Memorial Sloan Kettering Cancer Center)
11:20 – 11:40 IMMUNO-ONCOLOGY IN HCC: What’s all the fuss about?
Devalingam Mahalingam, MD PhD (Professor, Oncology, Northwestern)
11:40- 12:00 Q&A
12:00 – 12:45 Lunch Break
INTERVENTIONAL RADIOLOGY IN THE MANAGEMENT OF HCC
(Chair: Amit Singal MD)
12:45 – 13:00 ABLATION +/- Embolization: What’s the rationale?
Chris Molvar, MD (Assistant Professor, Loyola University)
13:00 – 13:15 TRANSARTERIAL THERAPY: Is the evidence there?
Riad Salem, MD, MBA (Professor, Radiology, Northwestern)
POST-TREATMENT FOLLOW-UP IN HCC
(Chair: Amir Borhani MD)
13:15 – 13:30 POST-THERAPY HCC IMAGING FOLLOW-UP: Why is it so hard?
Ahsun Riaz, MD (Associate Professor, Radiology, Northwestern)
13:30 – 13:45 IMPORTANCE OF MULTIDISCIPLINARY TUMOR BOARD in HCC: How does that work?
Sheila Eswaran, MD – (Associate Professor, Hepatology Rush University)
13:45- 14:00 Q&A
14:00 – 14:15 Coffee Break and Networking
PRECLINICAL RESEARCH IN HCC
(Chair: Parissa Tabrizian MD)
14:15 – 14:30 TRANSLATIONAL MODELS OF HCC: Do they really translate?
Sam Mouli, MD (Assistant Professor, Northwestern)
14:30 – 14:45 HEPATOCARCINOGENESIS AND MOLECULAR CLASSIFICATION: The Next Frontier
Anjana Pillai MD, MD (Associate Professor, University of Chicago)
TOP 10 DEVELOPMENTS IN HCC IN THE LAST DECADE
14:45 – 15:00 Riad Salem, MD MBA (Professor, Radiology, Northwestern)
15:00- 15:15 Q&A
*Hepatocellular Carcinoma TUMOR BOARD
(Case Presenter: Riad Salem, MD MBA)
15:15 – 16:30 Panel

  • Robert Lewandowski, MD
  • Karim Halazun, MD
  • Laura Kulik, MD
  • Ghassan Abou Alfa, MD
  • Amit Singal, MD
  • Sheila Eswaran, MD
  • Juan Caicedo, MD
  • Parissa Tabrizian, MD
  • Aparna Kalyan, MD
  • Ahsun Riaz, MD
Day 2: Friday May 27, 2022
07:15 – 08:00 Breakfast
HIHGLIGHTS FROM DAY 1 ILCA SCHOOL-take home points
08:00 – 08:15 Riad Salem, MD MBA
(Professor, Northwestern University)
MANAGEMENT OF INTRAHEPATIC CHOLANGIOCARCINOMA
(CHAIR: Laura Kulik, MD)
08:15 – 08:30 DIAGNOSIS AND STAGING OF ICC: Are all CCs the same?
Aparna Kalyan, MD (Associate Professor, Medical Oncology, Northwestern University)
08:30 – 09:00 SURGICAL RESECTION AND OLT for ICC: Do patients benefit?
Parissa Tabrizian, MD (Assistant Professor, Transplant Surgery, Mount Sinai)
09:00 – 09:20 MEDICAL MANAGEMENT OF ICC: Have we made progress?
Ghassan Abou-Alfa, MD (Professor of Medical Oncology, Weill-Cornell University, Memorial Sloan Kettering Cancer Center)
09:20 – 09:40 INTERVENTIONAL RADIOLOGY IN THE MANAGEMENT OF ICC: Where’s the beef?
Robert Lewandowski, MD (Professor, Northwestern University)
09:40- 10:00 Q&A
10:00 – 10:15 Coffee Break and Networking
Cholangiocarcinoma TUMOR BOARD
(Case Presenter: Ahsun Riaz, MD)
10:15 – 11:30 Panel

  • Robert Lewandowski, MD
  • Parissa Tabrizian MD
  • Karim Halazun, MD
  • Aparna Kalyan, MD
  • Ghassan Abou-Alfa, MD
  • Amit Singal, MD
  • Juan Caicedo, MD
  • Anjana Pillai, MD
  • Chris Molvar, MD
CLOSING COMMENTS ILCA School
11:30 – 11:40 Riad Salem, MD, MBA
(Professor, Radiology, Northwestern)
  • ILCA School of Liver Cancer. 26-27 May, 2022. Chicago, USA.
  • ILCA Single Topic Workshop. 9-10 June, 2022. Paris, France.
  • ILCA Webinar: Tumor heterogeneity in HCC analyzed by single cell analysis. 16 June, 2022.
  • ILCA Annual Conference. 1-4 September, 2022. Madrid, Spain.
x